Skip to content

Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00497913
Acronym
DCLE
Enrollment
52
Registered
2007-07-09
Start date
2007-08-31
Completion date
2008-04-30
Last updated
2008-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tennis Elbow

Keywords

Tennis Elbow, Botulinum Toxin

Brief summary

The purpose of this study is to determine whether a single injection of Dysport with a new protocol at forearm is effective in the management of chronic lateral epicondylitis.

Detailed description

Some studies valued the effectiveness of botulinum toxin. There is a great amount of controversy on the amount of botulinum toxin injected and the location of the injection. The purpose of the study is to compare the effectiveness of botulinum toxin injection with placebo at a new injection site at the forearm in the treatment of chronic tennis elbow unrelieved by corticosteroid injection and physiotherapy. It is a double blind randomized controlled trial.

Interventions

DRUGNaCl 0.9%
DRUGBotulinum Toxin A

Sponsors

Tehran University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pain: pain will be assessed as the physician touches lateral epicondyle or passively flexing the patient's wrist and while the patient extends his/her wrist or 3rd finger against resistance. Individuals who fulfill two or more of above will be considered to have lateral epicondylitis. * Symptom duration: should be at least 6 months. * Previous trial of complete course of physiotherapy and corticosteroid injection.

Exclusion criteria

* Rheumatoid arthritis * Generalized polyarthritis * Local elbow arthritis * Simultaneous medial epicondylalgia * Bilateral lateral epicondylitis * Neurologic deficits (abnormal light touch sensation, deep tendon reflexes abnormality, radicular pain, radial nerve entrapment, signs of nerve root compression, decreased muscle force, multiple sclerosis, seizures) * The use of corticosteroid in last 30 days * Simultaneous use of drugs other than acetaminophen or physical therapy in the course of study * Pregnancy * Breast-feeding * Previous hand surgery * Having a hobby or job that needs finger extension

Design outcomes

Primary

MeasureTime frame
Pain score on VAS at maximal grip, at maximal pinch, and during previous month at rest4 months

Secondary

MeasureTime frame
Patients subjective feeling of improvement.4 months
Tenderness on lateral epicondyle4 months
Pain sensation on resisted wrist extension, and passive wrist flexion4 months
Pain-free grip strength, and pinch strength4 months
Maximal grip strength, and pinch strength4 months

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026